Axelyf
Hafnarfj├╢r├░ur
About Axelyf
Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $7.4M
- Funding stage: Seed
- Last round: Seed (Aug 2025)
- Website: axelyf.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Life Science, Medical
Social Profiles
Canonical: https://fsome.com/organization/axelyf-20254 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.